MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Danaher Corporation ROA Ratio 2011-2026 | DHR
Annual ROA Ratio Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.33 | 5.03 | 5.64 | 8.55 | 7.73 | 4.79 | 4.85 | 5.54 | 5.34 | 5.64 | 6.96 | 7.02 | 7.77 | 7.26 | 7.25 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.55 | 4.33 | 6.25 |
Quarterly ROA Ratio Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.21 | 2.05 | 4.11 | 6.18 | 5.53 | 6.93 | 7.16 | 5.74 | 6.9 | 6.65 | 5.58 | 3.16 | 5.18 | 5.1 | 5.06 | 4.81 | 4.35 | 4.66 | 4.9 | 5.54 | 5.82 | 5.66 | 5.44 | 5.34 | 5.16 | 4.79 | 5.05 | 5.64 | 5.42 | 7.46 | 7.46 | 6.96 | 7.32 | 6.25 | 6.64 | 7.02 | 7.51 | 7.39 | 7.34 | 7.77 | 7.41 | 7.35 | 7.4 | 7.26 | 7.25 | 7.34 | 7.68 | 7.25 | 1.75 | 2.17 | 1.43 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.77 | 1.21 | 5.74 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
11.3 | $ 118.37 | -1.17 % | $ 36 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 20.14 | -2.04 % | $ 217 M |  China |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M |  Israel |
 |
Aspira Women's Health
AWH
|
-234.24 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 525.26 | 1.3 % | $ 15.2 B | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 22.07 | 25.61 % | $ 1.18 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
NeoGenomics
NEO
|
-7.94 | $ 8.14 | -6.22 % | $ 1.04 B | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 9.26 | -1.7 % | $ 2.01 B | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
10.73 | $ 28.88 | -0.65 % | $ 20 B |  Niderland |
 |
Co-Diagnostics
CODX
|
-189.54 | $ 1.42 | - | $ 1.89 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 24.4 | -0.89 % | $ 678 M | USA |
 |
Senseonics Holdings
SENS
|
-54.73 | $ 6.78 | -1.81 % | $ 283 M | USA |
 |
Soleno Therapeutics
SLNO
|
3.71 | $ 52.59 | 0.03 % | $ 2.67 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Neuronetics
STIM
|
-27.55 | $ 1.41 | 1.08 % | $ 93 M | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 180.6 | 0.02 % | $ 8.95 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Thermo Fisher Scientific
TMO
|
6.08 | $ 520.64 | -2.04 % | $ 196 B | USA |
 |
Interpace Biosciences
IDXG
|
72.63 | $ 2.2 | - | $ 9.73 M | USA |
 |
Trinity Biotech plc
TRIB
|
0.78 | $ 0.7 | -0.91 % | $ 61.9 M |  Irlanda |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | $ 56.1 | -2.65 % | $ 3.36 B | USA |
 |
Illumina
ILMN
|
-19.4 | $ 131.42 | -0.64 % | $ 20.9 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 16.12 | -0.31 % | $ 487 M | USA |
 |
Guardant Health
GH
|
-20.67 | $ 84.82 | -0.05 % | $ 10.6 B | USA |
 |
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
-67.95 | $ 2.84 | -3.24 % | $ 92.2 K | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.21 | 4.5 % | $ 5.08 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 117.7 | 1.03 % | $ 9.71 B | Irlanda |
 |
Waters Corporation
WAT
|
12.66 | $ 323.16 | -0.93 % | $ 19.2 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 267.93 | 0.45 % | $ 22.3 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Celcuity
CELC
|
-37.95 | $ 124.57 | 0.89 % | $ 5.82 B | USA |
 |
Myriad Genetics
MYGN
|
-51.78 | $ 5.13 | -1.25 % | $ 475 M | USA |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 83.18 | -0.91 % | $ 5.61 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 193.13 | 0.89 % | $ 21.4 B | USA |